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The Journal of Immunology
PTPN22 Is a Critical Regulator of Fcg Receptor–Mediated
Neutrophil Activation
Sonja Vermeren,* Katherine Miles,* Julia Y. Chu,* Donald Salter,† Rose Zamoyska,‡ and
Mohini Gray*
Neutrophils act as a first line of defense against bacterial and fungal infections, but they are also important effectors of acute and
chronic inflammation. Genome-wide association studies have established that the gene encoding the protein tyrosine phosphatase
nonreceptor 22 (PTPN22) makes an important contribution to susceptibility to autoimmune disease, notably rheumatoid arthritis.
Although PTPN22 is most highly expressed in neutrophils, its function in these cells remains poorly characterized. We show in this
article that neutrophil effector functions, including adhesion, production of reactive oxygen species, and degranulation induced by
immobilized immune complexes, were reduced in Ptpn222/2 neutrophils. Tyrosine phosphorylation of Lyn and Syk was altered in
Ptpn222/2 neutrophils. On stimulation with immobilized immune complexes, Ptpn222/2 neutrophils manifested reduced activa-
tion of key signaling intermediates. Ptpn222/2 mice were protected from immune complex–mediated arthritis, induced by the
transfer of arthritogenic serum. In contrast, in vivo neutrophil recruitment following thioglycollate-induced peritonitis and
in vitro chemotaxis were not affected by lack of PTPN22. Our data suggest an important role for PTPN22-dependent dephos-
phorylation events, which are required to enable full FcgR-induced activation, pointing to an important role for this molecule in
neutrophil function. The Journal of Immunology, 2016, 197: 000–000.
N
eutrophils are the most abundant peripheral blood
leukocytes in humans. As part of the innate immune
system, they provide an immediate response to infection
or injury. Neutrophils are rapidly activated by a variety of stimuli,
including bacterial peptides, complement, and immune complexes
(ICs). Autoimmune diseases, including rheumatoid arthritis (RA),
are associated with the generation of ICs that accumulate in sy-
novial fluid or are deposited on articular cartilage surfaces. They
engage and activate neutrophils via FcgRs (1, 2). Severe inflam-
mation follows neutrophil degranulation, releasing a plethora of
degradative enzymes and other inflammatory mediators (3). The
ensuing release of reactive oxygen species (ROS) and proteases
degrades articular cartilage, whereas secreted chemokines attract
further immune cells into the joint, driving chronic inflammation
(4). Thus neutrophilic inflammation forms a crucial part of the
inflammatory response, which needs to be resolved in a timely
manner to minimize host damage.
Protein tyrosine phosphatase nonreceptor 22 (PTPN22) is a
leukocyte-restricted phosphatase associated with an increased
risk in a range of autoimmune diseases, notably RA. The single
missense nucleotide polymorphism (SNP) C1858T encoding an
R620W substitution is the single most important non-MHC gene
contributor to RA susceptibility, and the second most important
for juvenile idiopathic arthritis according to candidate gene and
genome-wide association studies (5, 6). Although expression of
PTPN22 is highest in the neutrophil (7), its function in these
myeloid cells remains largely unknown. In T cells, PTPN22 has
been shown to suppress TCR signaling, for instance, by dephos-
phorylating key tyrosine residues within the activation loops of the
Src family kinases (SFKs) Lck and Fyn and the TCR adapter Zap-
70. At least in T cells, PTPN22 cooperates with the C-terminal Src
kinase; their physical interaction is critical to their synergistic
regulatory function. On a protein level, the disease-associated
R620W variant (R619W in the mouse) affects one of four proline-
rich regions in the C terminus of PTPN22. This disrupts PTPN22
binding to C-terminal Src kinase (8, 9).
The K/B3N serum transfer arthritis model of arthritis is in-
duced by administration of arthritogenic serum from arthritic
KRN 3 NOD donors. This bypasses the need for an adaptive
immune system–driven break in self-tolerance. It results in a
transient, but rapidly evolving, inflammatory arthritis that repro-
duces many of the hallmarks of RA (10, 11). In combination with
a range of experimental approaches, including genetic lineage
depletion and reconstitutions, this disease model has helped to
elucidate the important contribution of innate immune cells, no-
tably neutrophils, to the effector phase of RA (12–14).
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In this article, we present an analysis of PTPN22 function in the
neutrophil, concentrating on FcgR signaling owing to its prominent
role in autoimmune diseases. By performing functional assays with
isolated neutrophils from PTPN22-deficient mice and by analyzing
inflammation in K/B3N serum transfer arthritis, we demonstrate
that PTPN22 regulates FcgR neutrophilic inflammation.
Materials and Methods
Unless otherwise stated, materials were obtained from Sigma.
Abs
Abs directed against phosphotyrosine (PY1000), phospho–spleen tyrosine
kinase (Syk) (Y525/526), phospho-pan Src (Y527 and Y416), phospho-
Akt (S473), phospho-p38 (T180, Y182), and phospho-Erk (T202, Y204)
were from Cell Signaling Technology. Anti-Syk (clone 5F5) and anti-Lyn
(clone LYN-01) were from BioLegend. Anti-Ly6G (clone RC6-8C5) was
obtained from R&D Systems. Anti-BSA and anti-lactoferrin Abs were
from Sigma and an Ab against b-COP was a gift from Nick Ktistakis (The
Babraham Institute, Cambridge, U.K.). HRP-conjugated secondary Abs
were from Santa Cruz Biotechnology and Bio-Rad. Fluorescently conju-
gated Abs for flow cytometry were obtained from eBioscience (F4/80,
GR1), BioLegend (CD11b, CD11a, CD16/32, Ly6G, CD62L, CD19),
and BD (Ly6C).
PTPN22 mouse model
Generation of the PTPN22 mouse has been previously described (15).
Experimental mice were housed in individually ventilated cages in a
specific and opportunistic pathogen–free small animal barrier unit at the
University of Edinburgh. All animal work was approved by United
Kingdom Home Office Project license PPL60/4567.
Analysis of peripheral blood
Peripheral blood was sampled from the superficial temporal vein into so-
dium citrate. Leukocytes were stained using fluorescently conjugated Abs,
mixed with flow-check fluorospheres (Beckman Coulter) to determine cell
numbers, and RBCs were lysed (BD FacsLyse). Samples were analyzed by
flow cytometry using an LSR Fortessa (BD).
K/B3N serum transfer arthritis model
The K/B3N serum transfer model was induced using pooled arthritogenic
serum as previously described (10, 11, 16). Mice were scored for 20 d.
Each limb was scored as follows: 0, normal; 1, erythema or swelling in a
single digit; 2, erythema and swelling in two or more joints; 3, swelling of
the entire paw, including the hock joint. The sum of the score for each limb
(giving a maximum possible score of 12) was taken as a measure of the
extent of arthritis at that time point. Formalin-fixed samples were prepared
for histological examination by decalcification in EDTA. The 3-mm sec-
tions were stained with H&E. Immunostaining for Ly6G was performed
according to standard procedures without Ag retrieval, using a secondary
HRP-coupled Ab followed by a diaminobenzidine reaction. Analysis of
histological specimens occurred in a blinded fashion by a histopathologist,
using an Olympus BX51 microscope. Images were acquired with a Mi-
cropublisher 3.3RTV camera and Q Imaging software using 32, 320,
and 340 objectives.
Thioglycollate-induced sterile peritonitis
Sterile peritonitis was induced by injection of matured 4% Brewer’s thi-
oglycollate (BD) at a concentration of 20 ml/kg. Mice were sacrificed 3 h
after induction and peritoneal cells harvested following a peritoneal flush.
Cells were stained with fluorescently conjugated Abs and mixed with flow-
check fluorospheres (Beckman Coulter) to determine cell numbers, before
being analyzed by FACS using the LSR Fortessa (BD).
Neutrophil purification
Neutrophils were isolated from bone marrows of 12- to –14-wk-old sex- and
age-matched mice using discontinuous Percoll gradients (GE Healthcare
Amersham, Uppsala, Sweden) as previously described (17, 18), using
endotoxin-free reagents throughout.
Immobilized ICs and immobilization of adhesive proteins
For immobilized ICs, dishes were coated overnight at 4˚C with endotoxin
and fatty acid–free BSA in PBS (100 mg/ml), blocked with 1% fat-free
milk in PBS, and incubated with rabbit anti-BSA (1:2000). Control sur-
faces were treated identically, but not incubated with Ab. Some assays
were carried out with insoluble ICs, which had been generated as described
(19). Human fibrinogen (150 mg/ml), polyRGD (20 mg/ml), or, as a con-
trol, heat-inactivated FCS was adsorbed onto tissue culture–grade plastics
overnight at 4˚C and for 3 h at room temperature, respectively. All surfaces
were extensively washed with PBS prior to performing any assays.
ROS production assays
ROS production was measured by chemiluminescence in a Synergy H1 plate
reader (BioTek) using a luminol-based assay in luminescence grade 96-well
plates (Nunc; Thermo Scientific) essentially as previously described (20).
Measurements were started immediately following cell stimulation, and
light emission was recorded. Data output was relative light units per second.
Chemotaxis assays
For chemotaxis assays, neutrophils were resuspended in HBSS supplemented
with 15 mM HEPES pH 7.4 and 0.05% fatty acid and endotoxin-free BSA.
Dunn chambers were assembled as described (21), and chemotaxis assays
were carried out with MIP2 (R&D Systems) as chemoattractant. Cells were
monitored by time-lapse imaging for 30 min using an inverted RMDIB
microscope (Leica) equipped with temperature-controlled chamber, auto-
mated stage (Prior), Orca camera (Hamamatsu), and Micromanager image
acquisition software (Fiji). Paths of all individual neutrophils were tracked
using the manual tracking plug-in into ImageJ. Tracks were subsequently
analyzed using the Chemotaxis Tool (Ibidi) plug-in into Image J.
Transendothelial migration assays
Transendothelial migration (TEM) assays were carried out as previously
described (22). Briefly, 6.5-mm Transwell inserts with 3-mm polycarbonate
membranes (Corning Costar U.K.) were coated overnight with 2 mg/ml
fibronectin and seeded with 5 3 104 bEnd5 cells grown in DMEM sup-
plemented with 10% heat-inactivated FBS (both Life Technologies) as
described. Confluent bEnd5 cells were stimulated for 16 h with 5 nM
TNF-a, and 5 3 105 neutrophils were added into washed inserts that had
been placed into wells of 24-well plates in the presence of 0, 1, or 3 nM
MIP2 and allowed to migrate toward the chemoattractant. Transmigrated
neutrophils were labeled for GR1, and 8 randomly chosen fields of view
per 24 wells were photographed for counting (320 magnification using an
Evos cell imaging system [AMG]).
Adhesion assays
Neutrophils were allowed to adhere to immobilized IC or blocked surfaces
at 37˚C in 96-well plates. Dishes were then subjected to rapid orbital
shaking for 30 s before contents were flicked sharply out of wells prior to
cell fixation. Following extensive washing, four random images were taken
from each well for analysis of cell spreading (320 magnification; Evos
system).
Degranulation assays
Gelatinase granule release after plating neutrophils onto an immobilized IC-
coated surface, or following stimulation with fMLF and cytochalasin B, was
detected by in-gel zymography as previously described (20). Lactoferrin
release was assayed by making use of an Ab to human lactoferrin that had
previously been shown to cross-react with mouse protein essentially as
described (23, 24).
Analysis of protein phosphorylation
Neutrophils were plated onto immobilized IC-coated or control-treated dishes
for stimulation. For analysis of phosphorylation of protein kinase B (PKB),
Erk, and p38 MAPK, this was done as previously described (20, 25). For
analysis of Lyn and Syk, nonadherent cells and scraped, adherent cells were
combined for lysis in ice-cold 100 mM NaCl, 30 mM HEPES pH 7.4,
20 mM NaF, 1 mM EGTA, 1% Triton X-100, 1 mM benzamidine, 10 mg/ml
aprotinin, 1 mM PMSF, 1 mM Na3VO4, as well as mammalian protease
inhibitor mixture and phosphatase inhibitor mixture 2. After pelleting
detergent-insoluble material, proteins of interest were immunoprecipitated
using protein G agarose and Abs as indicated. Carefully washed beads were
boiled in sample buffer, and immunoprecipitated proteins and lysate controls
were separated by SDS-PAGE. Proteins were transferred to Immobilon
membrane (Millipore) for Western blotting, using Abs as indicated.
Cytokine-release assays
Cytokine-release assays were carried out using insoluble HSA–anti-HSA
ICs as stimulation. Insoluble ICs were prepared by titrating the point of
equivalence between Ag and Ab and monitoring the point of equivalence
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by measuring the absorbance at 450 nM as previously described (19).
Neutrophils were stimulated as indicated and cultured in round-bottom
96-well plates (Corning) in Dulbecco’s PBS supplemented with Ca2+ and
Mg2+, 1 g/l glucose, and 4 mM sodium bicarbonate in a humidified at-
mosphere at 37˚C and 5% CO2. After 6 h, supernatants were harvested for
cytokine analysis by ELISA (R&D research) according to the manufac-
turer’s instructions.
Statistical analysis
For kinetic experiments, the area under the graph was used for analysis.
Where data met the assumptions for parametric tests, two-tailed Student
t tests were applied. Otherwise, the nonparametric Mann–Whitney test was
used. A p value , 0.05 was considered statistically significant.
Results
Ptpn222/2 mice have already been described. In line with previous
reports, we found them to be fertile and without overt deleterious or
autoimmune phenotype (15, 26). Ptpn222/2 mice were character-
ized by mild peripheral blood neutrophilia (Fig. 1A), complement-
ing previous observations of increased B and T cell numbers in
Ptpn222/2 mice (26). To test whether this mild neutrophilia was a
result of inadequate activation of Ptpn222/2 neutrophils, we ana-
lyzed cell surface L-selectin/CD62L on freshly drawn peripheral
blood neutrophils from control and Ptpn222/2 mice. The findings
were similar, suggesting that the neutrophil activation status was not
affected by the absence of PTPN22 (Fig. 1B).
PTPN22 regulates neutrophil adhesion to immobilized ICs
Given the documented role of PTPN22, neutrophils, and ICs in
autoimmune-driven inflammatory arthritis, we analyzed IC-induced
effector functions with purified, bone marrow–derived neutrophils.
When plating the cells onto surfaces that had been coated with
immobilized ICs, fewer Ptpn222/2 than wild-type (WT) control
neutrophils were found to adhere firmly (Fig. 2A). In contrast, both
Ptpn222/2 and WT control neutrophils were equally able to spread,
once attached to the immobilized ICs (Fig. 2B, 2C). Similar results
were obtained with neutrophils that had been allowed to bind to
immobilized ICs for a shorter time (10 min; not shown). Neutro-
phils of both genotypes displayed very similar levels of surface
FcgRII/III (Fig. 2D). Because FcgRs and b2 integrins are known to
cross-talk extensively (27, 28), we also characterized cell surface
integrins. We observed no difference in cell surface expression of
the common leukocyte b2 integrins LFA-1/CD11a and noted a
similar increase in cell surface Mac-1/CD11b following stimulation
of Ptpn222/2 and WT control neutrophils with fMLF (Fig. 2D;
Supplemental Fig. 1). These data suggest that reduced adhesion of
Ptpn222/2 neutrophils was not due to reduced cell surface FcgR or
integrin receptor density.
PTPN22 regulates adhesion- and FcgR-dependent ROS
formation
FcgR engagement initiates specific neutrophil effector functions,
including ROS production and degranulation. To test whether
Ptpn222/2 neutrophils were able to generate ROS, we stimulated
cells with the phorbol ester PMA (Fig. 3A, 3B) or with a for-
mylated peptide (fMLF) (Fig. 3C, 3D). We noted no differences
between genotypes. In contrast, ROS formation by Ptpn222/2
neutrophils that had been plated onto immobilized ICs was
significantly lower than that seen with WT control neutrophils
(Fig. 3E, 3F). In line with well-established cross-talk between
FcgRs and integrins (27, 28), a similarly reduced generation of
ROS was also observed when neutrophils were plated on the b2
integrin ligand fibrinogen in the presence of TNF-a (Fig. 3G, 3H)
or onto the synthetic pan integrin ligand poly-Arg-Gly-Asp
(Fig. 3I, 3J). In conclusion, Ptpn222/2 neutrophils were charac-
terized by reduced ROS production following FcgR and integrin-
dependent stimulations.
PTPN22 regulates FcgR-dependent neutrophil degranulation
We next tested the ability of Ptpn222/2 neutrophils to degranulate
by measuring the release of lactoferrin and gelatinase, components
of neutrophil secondary and tertiary granules, respectively. As
observed with ROS production, Ptpn222/2 neutrophils degranu-
lated less efficiently than controls when plated onto immobilized
ICs, but not when they were stimulated with fMLF in the presence
of cytochalasin B (Fig. 4). These data argue that PTPN22 is re-
quired for optimal neutrophil effector functions involved in gen-
erating an inflammatory environment following stimulation of
FcgR (and integrins), and likely functioning in intracellular sig-
naling events downstream of receptor engagement.
To address whether PTPN22 may also be involved in cytokine
production, we analyzed release of TNF-a, MIP2 (a murine
equivalent of IL-8), and IL-1b by neutrophils that had been
stimulated with ICs. The extent of cytokine release triggered by IC
stimulation of neutrophils detected in these assays was very low,
and any reductions observed with Ptpn222/2 neutrophils did not
reach significance (Supplemental Fig. 2).
PTPN22 functions to activate signaling processes downstream
of FcgRs
PTPN22 is a protein tyrosine phosphatase. Signaling downstream of
FcgRs (and integrins) involves significant tyrosine phosphorylation.
Receptor-proximal key signaling proteins regulated include the ma-
jor neutrophil SFKs Lyn, Hck, and Fgr, as well as Syk. We analyzed
tyrosine phosphorylation of Syk immunoprecipitated from control
and Ptpn222/2 lysates from neutrophils that had been plated
onto immobilized ICs (IgG-BSA) or onto BSA (Fig. 5A). Mock-
stimulated Ptpn222/2 neutrophils were characterized by increased
Syk tyrosine phosphorylation (221.4 6 16.8% compared with con-
trol) as well as a second, slightly slower migrating band (indicated
by * in Fig. 5A) in comparison with WT controls. No differences
were apparent between Syk tyrosine phosphorylation of activated
WT and Ptpn222/2 neutrophils. Probing with an Ab that specifically
recognizes the activating phosphotyrosine residues Y519/Y520 in
mouse Syk revealed no differences between genotypes, with no signal
in basal control or Ptpn222/2 neutrophils. This finding suggested that
Syk tyrosine residue(s) other than Y519/Y520 are dephosphorylated
either directly or indirectly by PTPN22 in the neutrophil.
Lyn has been shown to act as an inhibitory SFK that phosphorylates
Syk in B cells (29, 30). We therefore analyzed Lyn in control and
Ptpn222/2 neutrophils. As a result of differential splicing, Lyn is
known to run as a doublet (31); however, at least with the Ab we used,
Lyn migrated as three distinct bands in basal and stimulated control
FIGURE 1. Ptpn222/2 mice have mild neutrophilia. (A) Blood samples
from 17 Ptpn222/2 and 22 matched control mice were labeled for CD11b and
Ly6G and analyzed by flow cytometry. Data (means 6 SEM) were pooled
from four separate experiments. (B) Cell surface L-selectin was analyzed in
unstimulated neutrophils from blood samples of eight WT and 7 Ptpn222/2
mice. Neutrophils were gated for analysis of CD62L staining; mean fluores-
cence intensity (MFI) values are plotted. **p , 0.01. ko, knockout.
The Journal of Immunology 3
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cells as well as in basal Ptpn222/2 cells. In lysates from stimulated
Ptpn222/2 neutrophils, we noticed a fourth Lyn band (Fig. 5B, ar-
row). Given the short time-frame of the stimulation used, this was
likely caused by a posttranslational modification of Lyn. We therefore
immunoprecipitated Lyn for analysis with phosphorylation-specific
Abs. This analysis revealed increased total tyrosine phosphorylation
of Ptpn222/2 neutrophils (150.1 6 6.2% compared with control) and
slight increases for both the activating Y527 residue (124.5 6 6.1%)
and the inhibitory Y416 residue (118 6 2.7%). In addition, phos-
phorylated Lyn from Ptpn222/2 neutrophils migrated slower than Lyn
from controls. This was particularly apparent for the phospho-Y527
(Fig. 5B, arrows). Taken together, our observations suggested that
PTPN22 regulates Lyn phosphorylation in the neutrophil.
To further address the implications of PTPN22-mediated dephos-
phorylation events, we also analyzed the activity status of some key
signaling intermediates that are activated downstream of SFK/Syk
signaling following activation of FcgRs. We probed for phospho-
PKB (also known as Akt), a read-out for the activity status of
phosphoinositide 3-kinase, phospho-Erk, and phospho-p38 MAPK.
All of these signaling intermediates were found to be mildly hypo-
phosphorylated in Ptpn222/2 neutrophils (Fig. 5C–F), indicating that
many signaling events downstream of FcgR engagement are influ-
enced by PTPN22 in the neutrophil. Finally, phosphotyrosine blots of
lysates from control and Ptpn222/2 neutrophils that had been plated
onto BSA or immobilized ICs showed reduced tyrosine phosphory-
lation in basal and activated Ptpn222/2 lysates (Supplemental Fig.
3). Together, these in vitro data suggested that PTPN22 phosphatase
performs activating dephosphorylation events in the neutrophil.
Ptpn222/2 mice are protected from K/B3N serum transfer
arthritis
Given the association of the human PTPN22 SNP, C1858T, with
RA, we tested whether the in vitro observations were relevant
in vivo. K/B3N serum was administered to control and Ptpn222/2
mice to induce serum transfer arthritis. Ptpn222/2 mice were sig-
nificantly protected from inflammatory joint disease compared with
age- and sex-matched WT controls. This protection was indepen-
dent of the sex of the recipient animals, and the trend was observed
with various doses of arthritogenic serum (Fig. 6, Table I). Ptpn222/2
mice were characterized by slower progression of the disease and
also reduced overall severity (Fig. 6A). The clinical observations in
the Ptpn222/2 mice were confirmed in histological sections taken
near the height of inflammation (on day 5), which showed a reduced
inflammatory cell infiltrate and few joint erosions when compared
with WT controls (Fig. 6B). Very few neutrophils were apparent in
ankle joint sections at this time point. Therefore, neutrophil infiltra-
tion was further evaluated at an earlier time point (day 2), when
neutrophil influx was expected to be maximal. Neutrophils in joint
sections were visualized by their distinct morphology and by Ly6G
staining (Fig. 6C, red arrows). In contrast to controls and in keeping
with the milder clinical disease, very few neutrophils were apparent
in ankle joints of Ptpn222/2 mice.
PTPN22 does not regulate neutrophil migration or recruitment
Neutrophils have been shown to organize their own recruitment
to the inflamed joint in K/B3N serum transfer arthritis. This re-
cruitment is regulated by a series of chemokines and cytokines
that are released by neutrophils and other synovial cells and that
mediate recruitment of consecutive waves of neutrophils to the
inflamed joint (32, 33). Because neutrophil migration into the
inflamed joint is an absolute requirement for the generation of
inflammation in this model (12–14), we analyzed chemotaxis of
Ptpn222/2 and control neutrophils. We observed no differences in
terms of Euclidian or total accumulated distances traveled or indeed
in the chemotactic directionality (the ratio between the Euclidian and
the total accumulated distance) in Dunn chamber chemotaxis toward
MIP2, indicating that Ptpn222/2 neutrophils undergo normal che-
motaxis (Fig. 7A–D). We further addressed whether the absence of
FIGURE 2. Ptpn222/2 mice have a defect in adhering to immobilized ICs. Neutrophils isolated from bone marrows of Ptpn222/2 [knockout (ko)] and
matched WT control mice were allowed to adhere for 20 min to wells that had been coated with immobilized ICs (IgG-BSA) or BSA as control, followed
by washing and fixing. Adherent and spread cells were counted in four randomly photographed fields of view of each well. (A) Total number of all adhered
cells. (B) Percentage of spread cells out of total. (A and B) Pooled data (means 6 SEM) from three separate experiments are presented. (C) Representative
examples of Ptpn222/2 and matched control neutrophils were allowed to adhere to immobilized ICs for 20 min. (D) Surface FcgRII/III, LFA-1, and Mac-1
of purified bone marrow–derived neutrophils from control and Ptpn222/2 mice were analyzed by flow cytometry. Neutrophils were or were not stimulated
with fMLF at 37˚C before being labeled with FITC-conjugated anti-GR1 and PE-conjugated anti-FcgRII/III, anti–Mac-1, or anti–LFA-1. GR1-positive cells
were gated, and PE staining was measured. Results were analyzed using FlowJo software. Black lines, WT neutrophils; gray lines, Ptpn222/2 neutrophils;
full lines, unstimulated cells; broken lines, stimulated cells. Experiments were performed with cells from four animals per genotype, and representative
examples are shown. See Supplemental Fig. 1 for a graphical representation of all experiments. **p , 0.01.
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PTPN22 might affect TEM, a key step required to enable neutro-
phils to leave the bloodstream. TEM was assessed using an in vitro
Transwell chemotaxis assay, in which neutrophils migrated through a
Transwell membrane supporting a monolayer of TNF-a–stimulated
murine endothelial cells. Ptpn222/2-deficient neutrophils migrated
through these activated endothelial cells as efficiently as WT controls
(Fig. 7E), suggesting that PTPN22 does not regulate neutrophil TEM
either. Finally, to test more definitively leukocyte recruitment in vivo,
we used the thioglycollate-induced sterile peritonitis model. Leuko-
cyte recruitment was analyzed at an early time point after induction
of peritonitis, when neutrophil recruitment peaks ahead of the re-
cruitment of other leukocytes (34). Again, and in line with the in vitro
observations above, there was no detectable defect in neutrophil re-
cruitment to the inflamed peritoneum of Ptpn222/2-deficient mice
(Fig. 7F). These observations demonstrate that PTPN22 does not
regulate neutrophil chemotaxis, TEM, or recruitment per se. Rather,
PTPN22 influences the activation of neutrophils in response to ICs.
Discussion
Our data show a significant protection of Ptpn222/2mice from IC-
driven K/B3N serum transfer arthritis. This model tests the ef-
fector phase of arthritis, which depends on neutrophil activation
for its clinical expression. Protection was observed with both
males and females under a number of experimental conditions
(Fig. 6, Table I). In contrast to our results, Wang et al. (35) and
Maine et al. (36) noted no protection from joint protection us-
ing the K/B3N model in Ptpn222/2 mice. We suspect that these
discrepancies may be the result of differences in the experimental
conditions. Researchers in both studies induced arthritis by
injecting larger amounts of arthritogenic serum than we did, in-
ducing a severe and prolonged arthritis. In contrast, we aimed for
submaximal transient arthritis, which would enable the detection
of subtle differences between experimental cohorts. It is con-
ceivable that the degree of neutrophil stimulation induced in these
studies overrode the protection afforded by the lack of PTPN22. In
addition, it is possible that differences in housing conditions
would lead to variations in the microbiome of the mice used for
the different studies. The gastrointestinal microbiota has recently
been recognized to regulate immunity and inflammatory responses
to in vivo challenges (37). Interestingly, K/B3N arthritis depends
heavily on the microbiome, with the T cell–independent effector
phase of K/B3N serum transfer arthritis being regulated by gut
microbiota (38, 39).
In vitro, with Ptpn222/2 neutrophils, we observed normal
chemotaxis and TEM toward MIP2. In vivo, normal levels of
neutrophil recruitment in the thioglycollate-induced model of
peritonitis were also apparent in Ptpn222/2 mice. This finding
argues against a role for PTPN22 in neutrophil migration or re-
cruitment (Fig. 7). In contrast, few neutrophils were observed in
the ankle joints of Ptpn222/2 mice following the induction of
K/B3N arthritis (Fig. 6). One explanation for this difference is
that alternative mechanisms may be used by neutrophils migrating
to different sites. Neutrophils have been shown to promote their
own recruitment to inflamed joints in the K/B3N serum transfer
arthritis model, by generating chemokines and inciting other cells
to do the same (32, 33). Therefore, an alternative explanation may
be that Ptpn222/2 neutrophils were less efficient at promoting a
suitable inflammatory environment to drive forward further waves
of neutrophil recruitment, as seen with the K/B3N serum transfer
FIGURE 3. Ptpn222/2 neutrophils are characterized by impaired
immune receptor–induced ROS production. Neutrophils isolated from
bone marrows of Ptpn222/2 [knockout (ko)] and matched WT control
mice were used to characterize ROS production following stimulation
with PMA (A and B), with fMLF (C and D), or following plating of
cells into wells coated with immobilized IC (IgG-BSA) or, as a con-
trol, BSA (E and F), into fibrinogen-coated wells in the presence
(stimulated) or absence (control) of TNF-a (G and H), or into wells coated
with the synthetic integrin ligand poly-Arg-Gly-Asp (polyRGD) or, as
a control, heat-inactivated FCS (I and J). Data shown (means 6 range)
are representative individual experiments (A, C, E, G, and I). Total light
emissions (means 6 SEM) expressed as percentage of the response
obtained with stimulated control neutrophils pooled from a minimum
of three separate experiments (B, D, F, H, and J). *p , 0.05. RLU, relative
light unit.
The Journal of Immunology 5
 at Edinburgh U
niversity on N
ovem
ber 4, 2016
http://w
w
w
.jimmunol.org/
D
ow
nloaded from
 
arthritis. In vitro, neutrophil activation by immobilized ICs was
defective, whereas stimulation induced by fMLF or PMA was
not (Figs. 3, 4). This observation indicates that PTPN22 is likely
to be preferentially involved in inflammation, induced following
integrin- and/or FcgR-dependent neutrophil activation.
Our observations are reminiscent of recent reports with Syk and
SFK triple knockout (ko) neutrophils that provided complete
protection from K/B3N serum transfer arthritis (40, 41). In these
reports, Syk, along with Lyn, Hck, and Fgr, was shown to be
dispensable for neutrophil recruitment. Yet they played a crucial
FIGURE 4. Ptpn222/2 neutrophils are
characterized by reduced IC-induced de-
granulation. (A and B) Gelatinase release by
control (wt) and Ptpn222/2 [knockout (ko)]
neutrophils plated into wells coated with
immobilized ICs (IgG-BSA) or, as a control,
BSA, or that had been stimulated by fMLF
in the presence of cytochalasin B (fMLF +
CB) was assessed by in-gel zymography. A
representative experiment (A) and pooled
data (means 6 SEM) from five separately
performed experiments (B) are presented. (C)
Lactoferrin release by control and Ptpn222/2
neutrophils plated into wells coated with
immobilized ICs (IgG-BSA) or, as a control,
BSA, or that had been stimulated by fMLF in
the presence of cytochalasin B (fMLF + CB)
was assayed by ELISA. Pooled data from
three separate experiments are presented.
Data presented are normalized to activated WT.
*p , 0.05.
FIGURE 5. Neutrophil PTPN22 regulates Lyn and Syk tyrosine phosphorylation, which affects the activity status of many signaling cascades. Neu-
trophils isolated from bone marrows of Ptpn222/2 [knockout (ko)] and matched WT control mice were allowed to adhere to immobilized ICs (IgG-BSA)
or, as a control, BSA for 12 min. (A and B) Lysates were prepared as detailed in Materials and Methods for Western blotting, using the indicated Abs; in
addition, Syk (A) or Lyn (B) was immunoprecipitated for analysis of phosphotyrosine as well as probing with Abs detecting specific tyrosine phosphor-
ylations in Syk/SFK proteins as indicated. Representative samples from at least three separately performed experiments are shown. (C–F) Lysates were
prepared and subjected to immunoblotting with Abs specific for phospho-PKB, phospho-Erk, and phospho-p38 MAPK (C–F). Blots were quantitated using
Image J software. (C) Representative blots. (D–F) Densitometry from five separate experiments (means6 SEM) was normalized to activated controls. *p,
0.05, **p , 0.01.
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role in FcgR-/integrin-mediated neutrophil effector functions, in-
cluding the generation of chemokines that are required to generate
inflammation (40, 41). We analyzed IC-induced chemokine gener-
ation by Ptpn222/2 neutrophils (Supplemental Fig. 2). Overall,
cytokine secretion in these experiments was low, and any differ-
ences between genotypes did not reach significance. It is likely such
differences will be more pronounced with inflammatory neutro-
phils, such as those within the synovial fluid of the arthritic joint,
than with unprimed, bone marrow–derived neutrophils. It will be
interesting to address these issues in more depth in the future.
Of note, our data suggest that tyrosine phosphorylation of both
Lyn and Syk is affected in Ptpn222/2 neutrophils (Fig. 5). We do
not yet know the identity of the affected phosphorylation sites, nor
whether these were direct events. It will be interesting to identify
the exact nature of neutrophil PTPN22 substrates in the future.
Given that the protection from K/B3N serum transfer arthritis
afforded by Ptpn222/2 mice was larger than that of any individual
SFK (Hck, Fgr, or Lyn) (41), it is interesting to speculate that
PTPN22 may contribute to regulating several SFKs, as well as other
potential substrates. Such a function would be in keeping with our
current understanding of PTPN22 function in T cells, in which
PTPN22 has been shown to dephosphorylate tyrosine residues
within the SFKs Lck and Fyn; ZAP-70, a Syk family protein; and
immune receptor tyrosine-based activation motifs in TCR-
associated proteins (26, 42, 43). Although these substrates are
not expressed in neutrophils, some of their family members are.
The findings presented in this article contrast sharply with
observations by others who analyzed the role of PTPN22
in lymphocytes. In T cells, PTPN22 functions as a negative reg-
ulator (44). For instance, TCR signaling and cell adhesion, me-
diated by Rap-dependent integrin inside-out signaling, were
increased in Ptpn222/2 mice (15). The activating role of PTPN22
downstream of FcgRs might be specific to the neutrophil, sug-
gesting that PTPN22 expression might individually modulate
various leukocytes that contribute to inflammation.
A missense SNP in PTPN22 (PTPN22-C1858T) predisposes
carriers to a number of autoimmune diseases, most notably RA,
systemic lupus erythematosus, and type 1 diabetes (43, 45, 46).
FIGURE 6. Ptpn222/2 mice are protected from K/B3N arthritis. K/B3N serum transfer arthritis was induced in Ptpn222/2 [knockout (ko)] and
matched control (wt) mice. (A) Clinical scores (means 6 SEM) of the experimental groups were plotted over 20 d. Four experiments were carried out with
five to eight animals in each experimental group; a representative experiment is shown; experimental groups behaved significantly differently; p = 0.02. (B)
Wax sections of decalcified joints were H&E stained to visualize joint erosion and leukocyte infiltration on day 5 after serum transfer. Representative
examples from sections obtained with right rear joints of arthritogenic serum–injected control (wt) and Ptpn222/2 (ko) mice are shown (scale bar, 500 mm);
panels wt9 and ko9 are higher power images of the boxed areas in panels wt and ko (scale bar, 50 mm). (C) Wax sections of decalcified joints were stained
with an Ab specific for Ly6G and counterstained with hematoxylin to visualize neutrophil infiltration at day 2 following administration of arthritogenic
serum. An arrow in Ptpn222/2 points out a rare neutrophil (scale bar, 25 mm).
Table I. Ptpn222/2 mice are protected from K/B3N arthritis
Recipient n Treatment
Mean Time
to Peak (d)
Mean Maximal
Score (6 SD)
Time at Peak
Intensity (d)
Median
Clinical Score
WT female 9 75 ml on day 0 6.2 8.6 (6 1.9) 2 3.8
ko female 9 75 ml on day 0 6.8 5.0 (6 1.9) 3.4 2.3
WT female 4 100 ml on day 0, 100 ml on day 2 5.8 10.25 (6 1.6) 4 8.25
ko female 3 100 ml on day 0, 100 ml on day 2 7 6.0 (6 1.7) 3.7 3.0
WT male 6 100 ml on day 0 4.2 9.8 (6 1.6) 2.3 4.0
ko male 6 100 ml on day 0 6.7 6.5 (6 2.9) 3.3 3.3
Irrespective of the gender of the recipient and of disease induction with a single injection or repeat injections with arthritogenic serum, Ptpn222/2 mice were characterized by
slower disease progression and reduced peak amplitude.
ko, knockout.
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However, it protects against Behc¸et’s disease and bowel inflam-
mation secondary to Crohn’s disease. Both of these diseases are
characterized by significant neutrophil-mediated chronic inflam-
mation (47, 48). Our understanding of PTPN22 function and
biochemistry, in particular in the neutrophil, lags behind studies of
its function in T cells. Indeed, the effects of the R620W mutation
are still being debated, with suggestions varying between the
mutation being activating, inactivating, and a hypomorph (45).
Moreover, observations in the mouse do not always tally with
those in humans, with studies in human cells split between those
suggesting the R620W variant is a gain of function (43, 49) and
others suggesting that it is a loss of function (50). In contrast, most
studies conducted in the mouse are more suggestive of a loss of
function mutation (51, 52). Furthermore, genetic background, as
well as the presence of other, potentially as yet unidentified sus-
ceptibility alleles, may play a role. R619W Ptpn22 knockins
largely replicated the phenotype of Ptpn222/2 lymphocytes,
suggestive of a loss of function mutation. One study suggested
R619W PTPN22 is prone to degradation (52). However, in a
separately derived knockin, protein stability was not impaired and
mice kept on a mixed 129 3 C57BL/6 background, which is more
prone to autoimmunity than pure C57BL/6, developed mild,
spontaneous autoimmune disease (51).
In ascribing to PTPN22 an activating function, our work is
suggestive, at least in the neutrophil, of a gain of function with
R620W PTPN22. In the context of the results described in this
article, it is hard to explain how a loss of function mutation would
trigger enhanced inflammation in immune receptor–dependent
contexts, such as the K/B3N model for arthritis. It will be very
interesting to test this hypothesis in the future by analyzing neu-
trophils derived from an R619W Ptpn22 point mutation knockin
mouse. As noted above, such mice have already been generated, but
their analysis to date has been restricted to cell types other than the
neutrophil (51, 52). One recent study analyzed effector functions in
human neutrophils derived from healthy donors and from RA pa-
tients who were or were not homozygous carriers of the SNP (53).
Although that study did not test any IC-dependent events, the au-
thors reported that neutrophils from homozygous carriers generate
increased ROS, release more calcium in response to other stimu-
lations, and undergo faster TEM than those from matched control
donors, in general agreement with the notion that R620W PTPN22
acts as a gain of function mutation in neutrophils.
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